The IPO review status on the Science and Technology Innovation Board of Shanghai Haihe Pharmaceutical Research and Development Co., Ltd. was changed to “Inquired”, and the sponsor was Guojin Securities.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.